PRINCETON, N.J., May 11 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced plans to release its first quarter 2009 results before market on Monday, May 18, 2009. The Company will hold a conference call that same day to discuss the results at 11:00 am EDT. Interested parties should call 800-299-8538 (domestic) or 617-786-2902 (international), with passcode 98098954 to access the call. You may also access this call via the Internet at:
http://phx.corporate-ir.net/playerlink.zhtml?c=107533&s=wm&e=2182603
For those who are unavailable to listen to the live broadcast, a replay will be available through June 18, 2009 and can be accessed by dialing 888-286-8010 (domestic), and 617-801-6888 (international). The passcode is 82270316.
About Derma Sciences
Derma Sciences is a global manufacturer and marketer of advanced wound care products. Its key product, MEDIHONEY(R), is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was the focus of a positive large-scale randomized controlled trial on leg ulcers. Derma's recently FDA cleared BIOGUARD(TM) Barrier Dressing is the Company's latest new product entrant into the $14 billion global wound care market. The barrier technology was licensed from Quick-Med Technologies, Inc. in Q1 of 2007. Derma also has in development DSC127, a novel angiotensin analog for accelerated wound healing and scar reduction. DSC127 was licensed from the
For more information about Derma Sciences, Inc., visit http://www.dermasciences.com.
Contact: Derma Sciences, Inc. Edward J. Quilty Chairman and CEO equilty@dermasciences.com (609) 514-4744 Allen & Caron Inc Rudy Barrio (US Investors) r.barrio@allencaron.com (212) 691-8087 Brian Kennedy (Media) brian@allencaron.com (212) 691-8087
SOURCE Derma Sciences, Inc. Copyright©2009 PR Newswire. All rights reserved |